I’m pretty interested in the potential for near term revenue (with Provisional Approval in Australia not dependent on P3 results).
From the recent corporate update.....
My understanding is that approval could be granted in about 12 months from first filings. From this link....
https://www.tga.gov.au/provisional-approval-implementation-arrangements
Hence I presume potential near term revenue around the middle of next year which would be before a P3 readout and the risk associated with that...
- Forums
- ASX - By Stock
- PAR
- The Future
PAR
paradigm biopharmaceuticals limited..
Add to My Watchlist
2.20%
!
46.5¢

The Future, page-7
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
46.5¢ |
Change
0.010(2.20%) |
Mkt cap ! $184.8M |
Open | High | Low | Value | Volume |
45.5¢ | 48.0¢ | 44.0¢ | $534.2K | 1.168M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 5245 | 45.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
47.0¢ | 10000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 23000 | 0.450 |
1 | 10000 | 0.440 |
1 | 23255 | 0.430 |
2 | 45000 | 0.425 |
2 | 21531 | 0.415 |
Price($) | Vol. | No. |
---|---|---|
0.470 | 10000 | 1 |
0.475 | 13560 | 2 |
0.480 | 90598 | 3 |
0.485 | 10000 | 1 |
0.490 | 18000 | 2 |
Last trade - 16.10pm 04/07/2025 (20 minute delay) ? |
Featured News
PAR (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Dr Michael Thurn, CEO & MD
Dr Michael Thurn
CEO & MD
SPONSORED BY The Market Online